Keyphrases
K562 Cells
100%
Fetal Hemoglobin Induction
100%
Stable Expression
100%
MicroRNA-34a (miR-34a)
100%
Fetal Hemoglobin
57%
Globin
42%
Histone Deacetylase 1 (HDAC1)
28%
Globin Genes
28%
K562
28%
Binding Site
14%
Transcription Factor
14%
Point mutation
14%
Western Blot Analysis
14%
Clinical Outcomes
14%
In Silico Analysis
14%
Cell Differentiation
14%
Hemoglobin S
14%
Molecular Targets
14%
Hemoglobin Level
14%
Repressor
14%
STAT3 Gene
14%
Globin Expression
14%
Gene Silencing
14%
MicroRNA
14%
Sickle Cell Anemia
14%
Negative Regulator
14%
Red Blood Cells
14%
Genetic Disease
14%
MicroRNA Genes
14%
Codon
14%
Severe Complications
14%
Functional Relevance
14%
Severe Symptoms
14%
Hemoglobin Polymerization
14%
Sickle Hemoglobin
14%
Glycophorin A
14%
Clinical Phenotype
14%
African People
14%
Developing Strategy
14%
Vaso-occlusion
14%
Post-transcriptional Gene Regulation
14%
Phosphorylated STAT3
14%
KLF1
14%
Hemoglobin Switching
14%
Erythropoietin Receptor
14%
Hemoglobin Expression
14%
Lentivirus Vector
14%
Novel microRNA
14%
Biochemistry, Genetics and Molecular Biology
Embryonic Hemoglobin
100%
K562 Cells
100%
Fetal Hemoglobin
100%
Stable Expression
100%
Globin
66%
STAT3
50%
Globin Gene
33%
MicroRNA
33%
HDAC1
33%
YY1
33%
Binding Site
16%
Point Mutation
16%
Transcription Factors
16%
Messenger RNA
16%
Western Blot
16%
Computer Model
16%
Cellular Differentiation
16%
Repressor
16%
Gene Silencing
16%
Hemocyte
16%
Lentivirus Vector
16%
Genetic Disorder
16%
Codon
16%
Gene Control
16%
Glycophorin
16%
KLF1
16%
Erythropoietin Receptor
16%